filmov
tv
New MPN Treatments and Drugs - Srdan Verstovsek, MD, PhD
Показать описание
Srdan Verstovsek, MD, PhD (University of Texas MD Anderson Cancer Center, Houston) discusses new MPN treatments and drugs at the 10th International Patient Symposium on Myeloproliferative Neoplasms in New York City on October 23, 2019.
0:02:10
MPN treatment: traditional, new and upcoming drug insights
0:33:24
Which MPN Treatment Is Right for You? What You Need to Know
0:25:57
New drugs for MPN
0:03:16
New MPN clinical trials & drugs in 2021
0:02:13
The future of MPN treatment: exciting agents and targets being investigated
0:24:52
Combination Therapy with JAK2 inhibitors in MPN
0:22:00
Update on Long-acting Interferons for MPN
0:01:52
MPN Treatment Tools and Advancement
0:01:13
MPN therapies: the current landscape
0:21:48
New treatments for MPN and priority setting
0:03:21
Looking beyond JAK inhibitors: novel targeted therapies and strategies for MPN treatment
0:23:06
New mouse models of MPN
0:04:22
Looking forward: MPN treatment
0:25:48
The WHO Updated Diagnostic Criteria for MPN
0:02:09
What Can MPN Patients Expect When Starting a New Treatment?
0:00:38
Comparing Two MPN Drugs
0:02:31
MPN transformation and treatment options
0:09:17
Common MPN Treatment Side Effects | Strategies for Management
0:02:04
Future directions in MPN therapy
0:31:29
Clinical Trials As an MPN Treatment Option: What You Should Know
0:14:03
MPN Patients and Drug Treatments Options during COVID-19
0:13:08
Essential Thrombocythemia: What Patients Should Know (2022) | Top MPN Specialist Dr. Ruben Mesa
0:02:22
What Are the Benefits of MPN Inhibitor Treatment?
1:32:46
A Conversation with an MPN Specialist: Old and New JAK Inhibitors
Комментарии